Abstract:
The purpose of this descriptive research was to examine the occurrence of Febrile Neutropenia (FN) and the relationship between age, sex, blood Albumin level, type of lymphoma, stage of cancer, number of chemotherapy cycles, comorbidities, self-care behavior, and physical activity with the occurrence of Febrile Neutropenia in persons with lymphoma who received chemotherapy. The study sample consisted of 114 individuals with lymphoma who received services at the Hematology Outpatient Department, a Tertiary care Hospital in Bangkok. The research tools used included personal data questionnaires, questionnaires on self-care behavior of individuals with lymphoma receiving chemotherapy, and questionnaires on physical activity. The research tools were of good quality, content validity, and reliability. Data were analyzed using descriptive statistics and examined for relationships using logistic regression analysis.The research findings revealed that 34.2% of individuals with lymphoma receiving chemotherapy experienced Febrile Neutropenia (FN), with the majority occurring during the first round of chemotherapy (48.7%) and FN occurring only once, accounting for 84.6%. Factors associated with the occurrence of FN included being female, age 60 or older, low levels of blood albumin (< 3.5 g/dL) ,advanced stage of cancer, the number of chemotherapy cycles, and the presence of comorbidities (OR=5.43, 1.68, 4.76, 1.62, 1.83, 2.33 respectively, p<.05). On the other hand, factors associated with a decreased risk of FN included physical activity (OR= 0.58, p<.05). Factors unrelated to FN included self-care behavior and cancer type (OR=0.62, 1.15 respectively, p>.05).